Free Trial

Swiss National Bank Has $14.84 Million Holdings in HealthEquity, Inc. (NASDAQ:HQY)

HealthEquity logo with Medical background

Key Points

  • The Swiss National Bank reduced its stake in HealthEquity, Inc. by 2.2%, owning approximately $14.84 million in shares after selling 3,800 during the first quarter.
  • HealthEquity's stock received multiple price target increases from various analysts, with Goldman Sachs raising it from $94 to $104, and a consensus rating of "Buy" with an average target of $118.55.
  • Key insider sales occurred in June, including an executive selling 58,000 shares, indicating significant changes in ownership among insiders alongside a total of 291,744 shares sold in recent months.
  • Need better tools to track HealthEquity? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Swiss National Bank cut its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 2.2% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 167,900 shares of the company's stock after selling 3,800 shares during the period. Swiss National Bank owned approximately 0.19% of HealthEquity worth $14,837,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in shares of HealthEquity by 9.7% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,166 shares of the company's stock worth $191,000 after buying an additional 192 shares during the last quarter. Ontario Teachers Pension Plan Board acquired a new position in shares of HealthEquity during the 1st quarter worth about $745,000. Charles Schwab Investment Management Inc. boosted its stake in shares of HealthEquity by 1.3% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,100,970 shares of the company's stock worth $97,293,000 after buying an additional 14,159 shares during the last quarter. New Age Alpha Advisors LLC boosted its stake in shares of HealthEquity by 755.8% during the 1st quarter. New Age Alpha Advisors LLC now owns 22,175 shares of the company's stock worth $1,960,000 after buying an additional 19,584 shares during the last quarter. Finally, Westfield Capital Management Co. LP acquired a new position in shares of HealthEquity during the 1st quarter worth about $49,787,000. 99.55% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. The Goldman Sachs Group increased their price objective on shares of HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 4th. Raymond James Financial restated a "strong-buy" rating and set a $120.00 price objective (up from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Barrington Research increased their price objective on shares of HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a research note on Thursday, June 5th. Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research note on Friday, June 6th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research note on Thursday, June 5th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, HealthEquity currently has a consensus rating of "Buy" and an average price target of $118.55.

View Our Latest Report on HQY

HealthEquity Stock Down 4.0%

Shares of HQY stock opened at $89.27 on Thursday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 4.06 and a current ratio of 4.06. The firm's 50-day moving average is $99.36 and its 200-day moving average is $97.59. The stock has a market cap of $7.72 billion, a price-to-earnings ratio of 65.16, a PEG ratio of 1.44 and a beta of 0.54. HealthEquity, Inc. has a 52-week low of $69.94 and a 52-week high of $116.65.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.81 by $0.16. The firm had revenue of $330.80 million for the quarter, compared to analysts' expectations of $322.25 million. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. During the same period in the prior year, the firm earned $0.80 EPS. Sell-side analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Elimelech Rosner sold 58,000 shares of the stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.56, for a total value of $6,528,480.00. Following the transaction, the executive vice president directly owned 75,689 shares of the company's stock, valued at $8,519,553.84. This represents a 43.38% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jon Kessler sold 134,183 shares of the stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the completion of the transaction, the director directly owned 253,510 shares in the company, valued at approximately $28,413,400.80. This represents a 34.61% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 291,744 shares of company stock valued at $32,705,007 in the last three months. 1.50% of the stock is currently owned by company insiders.

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Stories

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in HealthEquity Right Now?

Before you consider HealthEquity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.

While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom
3 Growth Stock Winners to Watch And 3 to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines